# Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)

> **NCT01133912** · PHASE1 · COMPLETED · sponsor: **Jungsil Ro** · enrollment: 13 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** paclitaxel, gemcitabine, lapatinib

## Key facts

- **NCT ID:** NCT01133912
- **Lead sponsor:** Jungsil Ro
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-06
- **Final completion:** 2011-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-01-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01133912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01133912, "Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01133912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*